|
JP2002065266A
(ja)
*
|
2000-08-28 |
2002-03-05 |
Teijin Ltd |
気道特異的トリプシン様酵素およびその利用法
|
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
AU2002359781A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Regents Of The University Of California |
Triple transgenic mouse model of alzheimer's disease
|
|
US20050026255A1
(en)
*
|
2002-06-25 |
2005-02-03 |
Morser John Michael |
Corin, a serine protease
|
|
JP2006507813A
(ja)
*
|
2002-10-04 |
2006-03-09 |
シエーリング アクチエンゲゼルシャフト |
置換体活性化配列を有する修飾されたヘプシン分子及びその使用
|
|
MXPA05013321A
(es)
*
|
2003-06-11 |
2006-03-09 |
Schering Ag |
Nuevas moleculas modificadas de corina que tienen secuencias de activacion sustitutiva y sus usos.
|
|
US7491865B2
(en)
*
|
2004-08-19 |
2009-02-17 |
Fred Hutchinson Cancer Research Center |
Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
|
|
EP1802193B1
(en)
|
2004-10-19 |
2014-04-30 |
Regeneron Pharmaceuticals, Inc. |
Method for generating a mouse homozygous for a genetic modification
|
|
EP2019837B1
(en)
*
|
2006-05-23 |
2011-03-23 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
GB0821624D0
(en)
*
|
2008-11-26 |
2008-12-31 |
Eisai London Res Lab Ltd |
Assay
|
|
EP3543256A1
(en)
*
|
2009-01-12 |
2019-09-25 |
Cytomx Therapeutics Inc. |
Modified antibody compositions, methods of making and using thereof
|
|
RU2425880C2
(ru)
*
|
2009-07-30 |
2011-08-10 |
Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН |
Способ получения трансгенных мышей
|
|
EP4502152A3
(en)
|
2009-10-06 |
2025-04-30 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified mice and engraftment
|
|
PT4233537T
(pt)
*
|
2011-02-15 |
2025-09-08 |
Regeneron Pharma |
Ratinhos humanizados para m-csf e utilizações dos mesmos
|
|
KR102295746B1
(ko)
|
2011-10-28 |
2021-09-01 |
리제너론 파아마슈티컬스, 인크. |
유전자 변형된 주요 조직적합성 복합체 마우스
|
|
RS63220B1
(sr)
|
2011-10-28 |
2022-06-30 |
Regeneron Pharma |
Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc)
|
|
SI2818478T1
(sl)
|
2011-10-28 |
2017-07-31 |
Regeneron Pharmaceuticals, Inc. |
Humanizirani il-6 in receptor il-6
|
|
EP2838558A1
(en)
*
|
2012-04-16 |
2015-02-25 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
|
|
US8962913B2
(en)
|
2012-06-18 |
2015-02-24 |
Regeneron Pharmaceuticals, Inc. |
Humanized IL-7 rodents
|
|
SG11201408554QA
(en)
*
|
2012-06-22 |
2015-02-27 |
Cytomx Therapeutics Inc |
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
|
|
KR102241962B1
(ko)
|
2012-09-07 |
2021-04-20 |
예일 유니버시티 |
유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
|
|
DK4389764T3
(da)
|
2012-11-05 |
2026-04-13 |
Regeneron Pharma |
Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
|
|
US9848587B2
(en)
|
2013-02-20 |
2017-12-26 |
Regeneron Pharmaceuticals, Inc. |
Humanized T cell co-receptor mice
|
|
MX2015010841A
(es)
|
2013-02-20 |
2016-05-09 |
Regeneron Pharma |
Modificacion genetica de ratas.
|
|
US20150342163A1
(en)
|
2013-02-22 |
2015-12-03 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex mice
|
|
SI2958937T1
(sl)
|
2013-02-22 |
2018-12-31 |
Regeneron Pharmaceuticals, Inc. |
Miš, ki izraža humanizirani poglavitni histokompatibilnostni kompleks
|
|
DK3456831T3
(da)
|
2013-04-16 |
2021-09-06 |
Regeneron Pharma |
Målrettet modifikation af rottegenom
|
|
BR112015030514A2
(pt)
|
2013-06-04 |
2017-08-29 |
Cytomx Therapeutics Inc |
Composições e métodos para conjugação de anticorpos ativáveis
|
|
HRP20231121T1
(hr)
|
2013-09-23 |
2023-12-22 |
Regeneron Pharmaceuticals, Inc. |
Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
|
|
JP6492095B2
(ja)
|
2013-10-15 |
2019-03-27 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
ヒト化ｉｌ−１５動物
|
|
US20150143559A1
(en)
|
2013-11-19 |
2015-05-21 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a humanized a proliferation-inducing ligand gene
|
|
MY183188A
(en)
*
|
2013-11-19 |
2021-02-18 |
Regeneron Pharma |
Non-human animals having a humanized b-cell activating factor gene
|
|
RS60398B1
(sr)
|
2014-04-08 |
2020-07-31 |
Regeneron Pharma |
Ne-humane životinje sa humanizovanim fc-gama receptorima
|
|
NO2785538T3
(cg-RX-API-DMAC10.html)
|
2014-05-07 |
2018-08-04 |
|
|
|
EP3482629B1
(en)
|
2014-05-19 |
2020-11-25 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified non-human animals expressing human epo
|
|
WO2015196051A1
(en)
|
2014-06-19 |
2015-12-23 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a humanized programmed cell death 1 gene
|
|
BR112017010793A2
(pt)
|
2014-11-24 |
2017-12-26 |
Regeneron Pharma |
animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
|
|
BR112017010490A2
(pt)
|
2014-12-05 |
2018-04-03 |
Regeneron Pharma |
roedor, polipeptídeo cd47, célula ou tecido de roedor isolado, célula-tronco emprionária de roedor, embrião de roedor, e, métodos de produzir um roedor, de fornecimento de um roedor, de enxerto de células humanas em um roedor, de avaliação de eficácia terapêutica de uma droga direcionada a células humanas e de avaliar as propriedades farmacocinéticas, de avaliar a toxicidade específica e inespecífica de uma droga direcionada ao cd47 humano.
|
|
ES2841353T3
(es)
|
2014-12-09 |
2021-07-08 |
Regeneron Pharma |
Animales no humanos que tienen un gen del grupo de diferenciación 274 humanizado
|
|
MX2017012829A
(es)
|
2015-04-06 |
2018-02-23 |
Regeneron Pharma |
Respuestas inmunitarias mediadas por células t humanizadas en animales no humanos.
|
|
CN108366548B
(zh)
|
2015-11-20 |
2021-10-08 |
瑞泽恩制药公司 |
具有人源化淋巴细胞活化基因3的非人动物
|
|
CN109068621B
(zh)
*
|
2016-02-29 |
2021-07-20 |
再生元制药公司 |
具有人源化的tmprss基因的啮齿类动物
|
|
KR101693243B1
(ko)
*
|
2016-06-15 |
2017-01-05 |
재단법인 한국파스퇴르연구소 |
인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도
|